Lymphomas and reactive lymphoid lesions in HIV infection

Blood Reviews

Volumn 12, Issue 3, 1998, Pages 154-162

  Bain, B J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; CELL DAMAGE; CELL PROLIFERATION; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LYMPH NODE; LYMPHOMA; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; T LYMPHOCYTE;

EID: 0031669518     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(98)90013-3     Document Type: Article

References (77)

1. Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiological features of primary HIV infection. Ann Intern Med 1996; 125: 257-264.
2. van Essen GG, Lieverse AG, Sprenger HG, Schirm J, Weits J. False positive Paul-Bunnell test in HIV seroconversion. Lancet 1988; ii: 747-748.
3. Sleeper TA, Horwitz CA, Hanson M, et al. Heterophile-negative mononucleosis-like illnesses with atypical lymphocytosis in patients undergoing seroconversions to the human immunodeficiency virus. Am J Clin Pathol 1988; 90: 169-174.
4. Ometto L, Menin C, Masiero S, et al. Molecular profile of Epstein-Barr virus in human immunodeficiency virus type 1-related lymphadenopathies and lymphomas. Blood 1997; 90: 313-322.
5. Henry K. Lymph nodes. In: Henry K, Symmers St C (eds). Systemic Pathology, 3rd Edn. Vol 7 Thymus, Lymph Nodes, Spleen and Lymphatics. Edinburgh: Churchill Livingstone, 1992: 271-284.
6. Gaidano G, Pastore C, Gloghino A, et al. Human herpesvirus type-8 (HHV-8) in haematopoietic neoplasia. Leuk Lymphoma 1996: 24: 257-266.
7. Knox KK, Carrigan DR. Disseminated HHV-6 infections in patients with AIDS. Lancet 1994; 343: 577-578.
8. Joshi VV, Gagnon GA, Chadwick EG, et al. The spectrum of mucosa-associated lymphoid tissue lesions in pediatric patients infected with HIV: a clinicopathological study of six cases. Am J Clin Pathol 1997; 107: 592-600.
9. Oksenhendler E, Autran B, Gorochov G, d'Agay MF, Seligmann M, Clauvel J-P. CD8 lymphocytosis and pseudotumoral splenomegaly in HIV infection. Lancet 1992; 340: 207-208.
10. Levenoglu H, Rosen Y. Nodular lymphoid hyperplasia of the gut in HIV infection. Am J Gastroenterol 1992; 87: 1211-1212.
11. Bachelez H, Hadida F, Gorochov G. Massive infiltration of the skin by HIV-specific cytotoxic CD8+ T cells. N Engl J Med 1996; 335: 61-62.
12. Majluf-Cruz A, Luna-Castanos G. Nieto-Cisneros L. AIDS-related pure red cell aplasia. Am J Hematol 1996; 51: 171-180.
13. Bolton-Maggs PH, Rogan PD, Duguid JK, Mutton KJ, Ball LM. Cold agglutinins in haemophiliac boys infected with HIV. Arch Dis Child 1991; 66: 732-733.
14. Ciaffoni S, Luzzati R, Roata C, Turrini A, Antonello O. Aprili G. Presence and significance of cold agglutinins in patients with HIV infection. Haematologica 1992; 77: 233-236.
15. Bain BJ. The haematological features of HIV infection. Br J Haematol 1997; 99, 1-8.
16. Karpatkin S. Nardi M. Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia. J Clin Invest 1992; 89: 356-364.
17. Kouri YH, Basch RS, Karpatkin S. B-cell subsets and platelet counts in HIV-1 seropositive subjects. Lancet 1992: 339: 1445-1446.
18. Silvestris F, Frassanito MA, Cafforio P, et al. Antiphosphatidylserine antibodies in human immunodeficiency virus-1+ patients correlate with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity. Blood 1996; 87: 5185-5195.
19. Brickner LA, Scannell KA, Sahud MA. Acquired factor V inhibitor in a patient with acquired human immunodeficiency syndrome. Am J Hematol 1996; 52: 332-333.
20. Mocroft AJ, Johnson MA, Sabin C, et al, for the Royal Free/Westminster Hospitals Collaborative Group. Staging system for clinical AIDS patients. Lancet 1995; 346: 12-16.
21. Levine AM. HIV-associated Hodgkin's disease: biologic and clinical aspects. Hematol Oncol Clin North Am 1996; 10: 1135-1148.
22. Biggar RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am 1996; 10: 997-1010.
23. Knowles DM. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 1996; 10: 1081-1109.
24. Harris NL, Jaffe ES, Stein H, Banks PM, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
25. Gaidano G, Pastore C, Gloghino A, et al. AIDS-related non-Hodgkin's lymphomas: molecular genetics, viral infection and cytokine deregulation. Acta Haematol 1996; 95: 193-198.
26. Moses AV, Williams SE, Strussenberg JG, et al. HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas. Nat Med 1997; 3, 1242-1249.
27. Przybylski GK, Goldman J, Ng VL, et al. Evidence for early B-cell activation preceding the development of Epstein-Barr virus-negative acquired immunodeficiency syndrome-related lymphoma. Blood 1996; 88: 4620-4629.
28. Writing Committee of NCI Non-Hodgkin's Lymphoma Classification Project. National Cancer Institute-sponsored study of non-Hodgkin's lymphoma. Summary and description of a working formulation. Cancer 1982; 49: 2112-2135.
29. Gaidano G. Pastore C, Gloghini A, et al. Genetic heterogeneity of AIDS-related small non-cleaved cell lymphoma. Br J Haematol 1997: 98: 726-732.
30. Carbone A, Dolcetti R, Gloghini A, et al. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study. Hum Pathol 1996; 27: 133-146.
31. Subar M, Neri A, Inghirami G, Knowles DM, Dalla Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988; 72: 667-671.
32. Brooks L, Thomas JA. The significance of Epstein-Barr virus in the pathogenesis of lymphoid and epithelial neoplasms. Current Diagnostic Pathology 1995; 2: 163-174.
33. Gaidano G, Pastore C, Gloghino A, et al. Human herpesvirus type-8 (HHV-8) in haematopoietic neoplasia. Leuk Lymphoma 1996: 24: 257-266.
34. Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1998; i: 292-293 and 373.
35. Tirelli U, Vaccher E, Zagonel V, et al. CD30 (Ki-l)-positive anaplastic large cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. J Clin Oncol 1995; 13: 373-380.
36. Tirelli U, Errante D, Carbone A, Gloghini A, Vaccher E. Malignant lymphomas in patients with HIV infection. Leuk Lymphoma 1996; 22: 245-257.
37. Nosari A, Cantoni S, Oreste P, et al. Anaplastic large cell (CD30/Ki-1+) lymphoma in HIV+ patients: clinical and pathological findings in a group of ten patients. Br J Haematol 1996; 95: 508-512.
38. Kersten MJ, Klein MR, Holwerda AM, Miedema F, van Oers MH. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. J Clin Invest 1997; 99: 1525-1533.
39. Berger C, Brousset P, McQuain C, Knecht H. Deletion variants within the NF-B activation domain of the LMP1 oncogene in acquired immunodeficiency syndrome-related large cell lymphomas, in prelymphomas and atypical lymphoproliferations. Leuk Lymphoma 1997; 26: 236-250.
40. Brink AATP, Dukers DF, van den Brule AJC, et al. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas. J Clin Pathol 1997; 50: 911-918.
41. Gires O, Zimber-Strobl U, Gonnella R. et al. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 1997; 16: 6131-6140.
42. Pastore C, Carbone A, Gloghini A, Volpe G, Saglio G, Gaidano G. Association of 6q deletions with AIDS-related diffuse large cell lymphomas. Leukemia 1996; 10: 1051-1053.
43. Camilleri-Brobt S, Davi F, Feuillard J, et al, and the French Study Group for HIV-Associated Tumors. Hum Pathol 1997: 28: 367-374.
44. Molina TJ, Deves F, Bigorgne C, et al. Detection of bcl-2 rearrangement in HIV-related follicular lymphoid hyperplasia. Br J Haematol 1996; 94: 705-708.
45. Camilleri-Brobt S, Davi F, Feuillard J, et al. High expression of latent membrane protein 1 (LMP1) of Epstein-Barr virus and BCL2 oncoprotein in acquired immunodeficiency-syndrome-related primary brain lymphomas. Blood 1995; 86: 432-435.
46. Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 1989; 73: 792-799.
47. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-1191.
48. Jaffe E. Primary body-cavity-based AIDS-related lymphomas: evolution of a new disease entity. Am J Clin Pathol 1996; 105: 141-142.
49. Ansari MQ, Dawson DB, Nador R, et al. Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 1996; 105: 221-229.
50. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 33: 645-656.
51. Carbone A. Gaidano G. HHV-8-positive body-cavity-based lymphoma: a novel lymphoma entity. Br J Haematol 1997: 97: 515-522.
52. Carbone A, Gloghini A, Canzonieri V, Tirelli U, Gaidano G. AIDS-related non-Hodgkin's lymphomas with plasma cell differentiation. Blood 1997; 90: 1337-1338.
53. Tasaka T, Said JW, Park D, Koeffler HP. KSHV sequences in lymphoid tissues. Blood 1996; 88 Suppl 1: 500a.
54. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997; 89: 413-1420.
55. McGrath MS, Shiramizu B, Meeker T, Kaplan L, Herndier B. AIDS-associated polyclonal lymphoma: identification of a new HIV-associated disease process. JAIDS 1991; 4: 408-415.
56. McGrath MS. HIV-associated lymphoma. Leukemia 1996; 10: 1077-1078.
57. Ng VL, Hurt MH, Herndier BG, Fry KE, McGrath MS. VH gene use by HIV type 1-associated lymphoproliferations. AIDS Res Hum Retroviruses 1997: 13: 135-149.
58. Shiramizu B, Herndier BG, McGrath MS. Identification of a common clonal human immunodeficiency virus integration site in human immunodeficiency virus-associated lymphomas. Cancer Res 1994; 54: 2069-2072.
59. MacGrogan G, Vergier B, Dubos P, et al. CD30-positive cutaneous large cell lymphomas: a comparative study of clinicopathologic and molecular features of 16 cases. Am J Clin Pathol 1996; 105: 440-450.
60. Merlio JPh, MacGrogan G, Rivel J, Beylot J, Vital C. CD30-positive cutaneous lymphoma. Am J Clin Pathol 1996; 106: 800-801.
61. Krenacs L, Wellman A, Sorbara L, et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T-and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997; 89: 980-989.
62. Coker RJ, Law R, Isaacson PG, Kelly SA, Price P, Weber J. Mucosa-associated gastric lymphoma occurring in an HIV-antibody positive patient. AIDS 1992; 6: 336-337.
63. Teruya-Feldstein J, Temeck BK, Sloas MM, et al. Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient. Am J Surg Pathol 1995; 19: 357-363.
64. McClain KL, Joshi VV, Murphy SB. Cancers in children with HIV infection. Hematol Oncol Clin North Am 1996; 10: 1189-1201.
65. Koh HK, Charif M, Weinstock MA. Epidemiology and clinical manifestations of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995; 8: 943-960.
66. Pulik M, Lionnet F, Genet P, Petitdidier C, Jary L, Fourcade C. CD3+ CD8+ CD56- clonal large granular lymphocyte leukaemia and HIV infection. Br J Haematol 1997; 98: 444-445.
67. Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD. Increased incidence of Hodgkin's disease in homosexual men with HIV infection. Ann Intern Med 1992; 117: 309-311.
68. Reynolds P, Saunders LD, Layefsky ME, Lemp GF. The spectrum of acquired immunodeficiency syndrome -associated malignancies in San Francisco, 1980-1987. Am J Epidemiol 199; 137: 19-30.
69. Lyter DW, Bryant J, Thackeray R, Rinaldo CR, Kingsley LA. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 1995: 13: 2540-2546.
70. Bellas C, Sant'n A, Manzanal A, et al. Pathological, immunological, and molecular features of Hodgkin's disease associated with HIV infection: comparison with ordinary Hodgkin's disease. Am J Surg Pathol 1996; 20: 1520-1524.
71. De Re V, De Vita S, Dolcetti R, Boiocchi M. Association between B-type Epstein-Barr virus and Hodgkin's disease in immunocompromised patients. Blood 1993; 82: 328-329.
72. Dolcetti R, Zancai P, De Re V, et al. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Blood 1997; 89: 1723-1731.
73. Lefrdre JJ, Debbia M, Lambin P. Prospective follow-up of monoclonal gammopathies in HIV-infected individuals. Br J Haematol 1993; 84: 151-155.
74. Turbat-Herrera EA, Hancock C, Cabella-Inchausti B, Herrera GA. Plasma cell hyperplasia and monoclonal paraproteinemia in human immunodeficiency virus-infected patients. Arch Pathol Lab Med 1993; 234: 165-173.
75. Crapper RM, Deam DR, Mackay IR. Paraproteinaemias in homosexual men with HIV infection: lack of association with abnormal clinical or immunologic findings. Am J Clin Pathol 1987; 88: 348-351.
76. Kumar S, Kumar D, Schnadig VJ, Selvanayagam P, Slaughter DP. Plasma cell myeloma in patients who are HIV-positive. Am J Clin Pathol 1994; 102: 633-639.
77. Konrad RJ, Kricka LJ, Goodman DBP, Goldman J, Silberstein LE. Myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient. Lancet 1993; 328: 1817-1819.